Volume 64, Issue 5, Pages (November 2003)

Slides:



Advertisements
Similar presentations
Renal involvement in hepatitis C infection: Cryoglobulinemic glomerulonephritis Giuseppe D’Amico Kidney International Volume 54, Issue 2, Pages
Advertisements

Epidemiology of end-stage renal disease: International comparisons of renal replacement therapy Francesco Paolo Schena Kidney International Volume 57,
Renal Stress Testing in the Assessment of Kidney Disease Lakhmir S. Chawla, Claudio Ronco Kidney International Reports Volume 1, Issue 1, Pages (May.
Inflammation and Cancer: IL-6 and STAT3 Complete the Link
Cellular mechanisms of renal osteodystrophy
Focus on hereditary endocrine neoplasia
Renal vitamin D receptor expression and vitamin D renoprotection
Volume 83, Issue 3, Pages (March 2013)
Management of advanced renal cancer
Impact of new dialysis solutions on peritonitis rates
The Case ∣ Acute renal failure and anemia
International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia  Brett Delahunt, John R. Srigley, Lars Egevad,
Shunsuke Furuta, David R.W. Jayne  Kidney International 
Cysteine cathepsins (proteases)—On the main stage of cancer?
Volume 80, Issue 10, Pages (November 2011)
Progression of renal failure and hypertensive nephrosclerosis
Volume 77, Issue 1, Pages 6-8 (January 2010)
Gene electrotransfer: Potential for gene therapy of renal diseases
Peritubular capillaritis in the renal allograft takes center stage
Volume 58, Issue 1, Pages (July 2000)
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Volume 70, Issue 11, Pages (December 2006)
Kamila Czene, Ph.D., Kari Hemminki  Kidney International 
Volume 86, Issue 2, Pages (August 2014)
Volume 56, Issue 4, Pages (October 1999)
Volume 71, Issue 6, Pages (March 2007)
Spontaneous self-alkalinization in spontaneous tumor lysis syndrome
Volume 70, Issue 12, Pages (December 2006)
Ferruh Artunc, Friedhelm Hildebrandt, Kerstin Amann 
Fructose intake as a risk factor for kidney stone disease
Macrophages and hypoxia in human chronic kidney disease
An unusual cause of acute renal failure
De novo multifocal renal cell carcinoma in the renal allograft
Volume 74, Issue 6, Pages (September 2008)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Presentation of the 2003 Jean Hamburger Award to Robert W. Schrier
Methods for guideline development
Volume 56, Issue 4, Pages (October 1999)
Nephrology Crossword: Glomerulonephritis
The initiation and progression of sickle cell nephropathy
Unilateral renal cystic disease
Volume 76, Issue 1, Pages 6-7 (July 2009)
Acute phosphate nephropathy
Volume 73, Issue 9, Pages (May 2008)
Volume 82, Issue 9, Pages (November 2012)
Volume 79, Issue 5, Pages (March 2011)
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Volume 80, Issue 10, Pages (November 2011)
Volume 83, Issue 4, Pages (April 2013)
A new regulator of the vacuolar H+-ATPase in the kidney
Acceptance of the 1999 Jean Hamburger Award
Is complement a target for therapy in renal disease?
Volume 70, Issue 3, Pages (August 2006)
Volume 74, Issue 9, Pages (November 2008)
Volume 70, Issue 5, Pages (September 2006)
Volume 82, Issue 9, Pages (November 2012)
T cells and T-cell receptors in acute renal failure
Volume 70, Issue 10, Pages (November 2006)
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Volume 80, Issue 9, Pages (November 2011)
Volume 74, Issue 10, Pages (November 2008)
Volume 163, Issue 4, (November 2015)
Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors  Lynn Stothers, William A. Gourlay, Li.
The Ebf1 knockout mouse and glomerular maturation
Ronen Levi, Justin Silver  Kidney International 
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Alex B. Magil, Kathryn Tinckam  Kidney International 
Presentation transcript:

Volume 64, Issue 5, Pages 1671-1674 (November 2003) VHL down-regulation and differential localization as mechanisms in tumorigenesis  Yih-Horng Shiao, Asta Forsti, Lars Egevad, Lucy M. Anderson, Per Lindblad, Kari Hemminki  Kidney International  Volume 64, Issue 5, Pages 1671-1674 (November 2003) DOI: 10.1046/j.1523-1755.2003.00257.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Determination of von Hippel-Lindau (VHL) antibody specificity using normal kidneys and cancer-positive controls (magnification, 200×). Nonneoplastic areas of kidney: Ig32 antibody (A and C); Ab-1 antibody (B); IgG1 isotype antibody (D). Breast cancer: Ig32 antibody (E); omission of Ig32 antibody (F). Kidney International 2003 64, 1671-1674DOI: (10.1046/j.1523-1755.2003.00257.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 von Hippel-Lindau (VHL) brown immunosignal from Ig32 antibody in renal cell carcinomas. Cell membrane (A and B) (magnification, 200×); cytoplasm (C and D) (magnification, 200×); comparison of signal between nonneoplastic [on the right (E) and at the top-right corner (F)] (magnification, 100×) and corresponding tumor areas [on the left (E) and at the bottom (F)]. Kidney International 2003 64, 1671-1674DOI: (10.1046/j.1523-1755.2003.00257.x) Copyright © 2003 International Society of Nephrology Terms and Conditions